Lithium iodide → 1-[2-(4-Nitrophenyl)ethyl]-4-(benzofurazan-5-carbonyl)piperidine hydrochloride
Reaction equation
[ClH:1].[N:2]1[O:6][N:5]=[C:4]2[CH:7]=[C:8]([C:11]([CH:13]3[CH2:18][CH2:17][NH:16][CH2:15][CH2:14]3)=[O:12])[CH:9]=[CH:10][C:3]=12.[N+:19]([C:22]1[CH:30]=[CH:29][C:25]([CH2:26][CH2:27]Br)=[CH:24][CH:23]=1)([O-:21])=[O:20].C(=O)(O)[O-].[Na+].[I-].[Li+]>C(O)C>[ClH:1].[N+:19]([C:22]1[CH:30]=[CH:29][C:25]([CH2:26][CH2:27][N:16]2[CH2:17][CH2:18][CH:13]([C:11]([C:8]3[CH:9]=[CH:10][C:3]4[C:4]([CH:7]=3)=[N:5][O:6][N:2]=4)=[O:12])[CH2:14][CH2:15]2)=[CH:24][CH:23]=1)([O-:21])=[O:20]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
In the manner described in Example 14, 4-(benzofurazan-5-carbonyl)piperidine hydrochloride (80 mg, 0.3 mmol), 4-nitrophenethyl bromide (172 mg, 0.75 mmol), sodium bicarbonate (101 mg, 1.2 mmol), and lithium iodide (1 mg) in ethanol (3 ml) under reflux for 3 hours gave, after purification by flash column chromatography on silica gel, eluting with CH2Cl2 /CH3OH/NH3 (Aq.); 96:4:0.4 and treatment with ethanolic HCl, the hydrochloride as a white solid (44 mg, 35%), mp 238°-240° C.
Workup
- temperatureunder reflux for 3 hours
- customgave
- customafter purification by flash column chromatography on silica gel
- washeluting with CH2Cl2 /CH3OH/NH3 (Aq.)
Sources & evidence
- ORD record
- ord-4e2807ca03424b35a8fb56d0c54070f7
- Source dataset
- uspto-grants-1992_05
- Patent number
- US05112824
Reaction notes
Loading…